Wolverine Trading
ACAD icon

Wolverine Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

Wolverine Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$723K Buy
+33,900
New +$802K ﹤0.01% 3264
2024
Q4 		– Sell
-16,400
Closed -$257K – 5172
2024
Q3 		$257K Buy
+16,400
New +$274K ﹤0.01% 3791
2024
Q2 		– Sell
-13,800
Closed -$255K – 4375
2024
Q1 		$255K Buy
+13,800
New +$342K ﹤0.01% 3536
2023
Q4 		– Sell
-26,300
Closed -$548K – 4422
2023
Q3 		$548K Buy
+26,300
New +$714K ﹤0.01% 2681
2021
Q2 		– Sell
-63,200
Closed -$1.63M – 5725
2021
Q1 		$1.63M Buy
+63,200
New +$2.78M ﹤0.01% 2160
2020
Q4 		– Sell
-15,000
Closed -$606K – 4719
2020
Q3 		$606K Buy
15,000
+6,700
+81% +$289K ﹤0.01% 2593
2020
Q2 		$400K Buy
+8,300
New +$398K ﹤0.01% 2988
2020
Q1 		– Sell
-39,800
Closed -$1.72M – 4522
2019
Q4 		$1.72M Buy
+39,800
New +$1.73M ﹤0.01% 1960
2019
Q2 		– Sell
-32,400
Closed -$870K – 4331
2019
Q1 		$870K Sell
32,400
-21,100
-39% -$493K ﹤0.01% 2216
2018
Q4 		$837K Buy
53,500
+7,200
+16% +$140K ﹤0.01% 2130
2018
Q3 		$961K Buy
+46,300
New +$728K ﹤0.01% 2409
2017
Q4 		– Sell
-28,400
Closed -$1.07M – 4719
2017
Q3 		$1.07M Sell
28,400
-5,200
-15% -$169K ﹤0.01% 1856
2017
Q2 		$964K Sell
33,600
-25,000
-43% -$745K ﹤0.01% 1773
2017
Q1 		$2M Sell
58,600
-51,100
-47% -$1.8M 0.01% 1193
2016
Q4 		$3.16M Buy
109,700
+15,200
+16% +$402K 0.02% 1027
2016
Q3 		$3.09M Buy
+94,500
New +$3.2M 0.01% 1014

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Wolverine Trading's ACAD Position: Q4 2023 in Review

Wolverine Trading sold out of Acadia Pharmaceuticals (ACAD) in Q4 2023, closing a stake of 15,149 shares — an estimated $316K sold.

Wolverine Trading first reported a position in ACAD in Q3 2016 and held it in 9 quarters. The position peaked at $1.43M in Q1 2017. 275 funds tracked by Wall St. Rank hold ACAD as of Q4 2023.

  • Wolverine Trading reported no remaining Acadia Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Wolverine Trading sold 15,149 Acadia Pharmaceuticals shares in Q4 2023, an estimated $316K.
  • Wolverine Trading first reported a position in Acadia Pharmaceuticals in Q3 2016 and held it in 9 quarters.
  • Wolverine Trading's Acadia Pharmaceuticals position peaked at $1.43M in Q1 2017.
  • 275 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2023.

Based on Wolverine Trading's 13F filing for Q4 2023, filed 14 Feb 2024.